Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4.
Bhoj VG, Li L, Parvathaneni K, Zhang Z, Kacir S, Arhontoulis D, Zhou K, McGettigan-Croce B, Nunez-Cruz S, Gulendran G, Boesteanu AC, Johnson L, Feldman MD, Radaelli E, Mansfield K, Nasrallah M, Goydel RS, Peng H, Rader C, Milone MC, Siegel DL.
Bhoj VG, et al. Among authors: zhang z.
Mol Ther Oncolytics. 2021 Jan 26;20:387-398. doi: 10.1016/j.omto.2021.01.012. eCollection 2021 Mar 26.
Mol Ther Oncolytics. 2021.
PMID: 33614919
Free PMC article.